Tildipirosin is primarily used in veterinary medicine for the treatment of respiratory diseases in cattle and swine. It is effective against bacterial pathogens such as Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni, which are commonly associated with bovine respiratory disease (BRD). Due to its long half-life and high tissue penetration, especially in lung tissue, it provides sustained therapeutic concentrations with a single injection. This makes it a practical choice for field use in livestock, reducing the need for repeated handling of animals. Its application helps improve animal welfare and productivity in commercial farming settings by controlling respiratory infections efficiently.